CliffBio
small molecule

TERBINAFINE HYDROCHLORIDE

TERBINAFINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyCipla →See this company's full patent-cliff portfolio

Drug detail

Brand nameTERBINAFINE HYDROCHLORIDE
Active ingredientTERBINAFINE HYDROCHLORIDE
StrengthEQ 250MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2007
Marketing statusRX

More from Cipla

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

TERBINAFINE HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio